Peng Xie, Ph.D. - Publications
Affiliations: | 2008 | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Biological ChemistryYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Guo B, Xie P, Su J, Zhang T, Li X, Liang G. Fangchinoline suppresses the growth and invasion of human glioblastoma cells by inhibiting the kinase activity of Akt and Akt-mediated signaling cascades. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 26408176 DOI: 10.1007/s13277-015-3990-1 | 0.325 | |||
2012 | Qin J, Xie P, Ventocilla C, Zhou G, Vultur A, Chen Q, Liu Q, Herlyn M, Winkler J, Marmorstein R. Identification of a novel family of BRAF(V600E) inhibitors. Journal of Medicinal Chemistry. 55: 5220-30. PMID 22537109 DOI: 10.1021/Jm3004416 | 0.562 | |||
2009 | Xie P, Streu C, Qin J, Bregman H, Pagano N, Meggers E, Marmorstein R. The crystal structure of BRAF in complex with an organoruthenium inhibitor reveals a mechanism for inhibition of an active form of BRAF kinase. Biochemistry. 48: 5187-98. PMID 19371126 DOI: 10.1021/Bi802067U | 0.555 | |||
2008 | Luo C, Xie P, Marmorstein R. Identification of BRAF inhibitors through in silico screening. Journal of Medicinal Chemistry. 51: 6121-7. PMID 18783202 DOI: 10.1021/Jm800539G | 0.569 | |||
2008 | Xie P, Williams DS, Atilla-Gokcumen GE, Milk L, Xiao M, Smalley KS, Herlyn M, Meggers E, Marmorstein R. Structure-based design of an organoruthenium phosphatidyl-inositol-3-kinase inhibitor reveals a switch governing lipid kinase potency and selectivity. Acs Chemical Biology. 3: 305-16. PMID 18484710 DOI: 10.1021/Cb800039Y | 0.57 | |||
Show low-probability matches. |